Effect of Diallyl Trisulfide on TNF-a-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Effect of Diallyl Trisulfide on TNF-a-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells.

Kanga KJW, Mendonca P, Soliman KFA, Ferguson DT, Darling-Reed SF. Effect of Diallyl Trisulfide on TNF-a-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells. Anticancer Res. 2021 Dec; 41(12):5919-5933.

View in: PubMed

authors with profiles

Karam F. Soliman

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support